Forward-Looking Statements & Disclaimers
This presentation contains “forward-looking statements” as that term is defined in Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this presentation that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations, or intentions regarding the future. These forward-looking statements generally can be identified by phrases such as QHSLab, Inc.. (“USAQ”) or its management “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates,” or other words or phrases of similar importance.
Such forward-looking statements include, among other things, the development, costs, and anticipated results of new business opportunities. Actual results could differ from those projected in these forward-looking statements made as of this presentation date, and we assume no obligation to update any forward-looking statements. Our actual results may differ materially from those stated or implied in such forward-looking statements due to risks and uncertainties associated with our business, including the risk factors disclosed in our public filings. Although we believe that any beliefs, plans, expectations, and intentions in this presentation are reasonable, there can be no assurance that any such beliefs, plans, expectations, or intentions will prove accurate. Investors should review all of the information set forth herein and in our filings with the Securities and Exchange Commission and understand the risk factors and the inherent uncertainties associated with new business opportunities and development stages. Any use of this information for any purpose other than in connection with the consideration of an investment in QHSLab, Inc.. may subject the user to criminal and civil liability.
This presentation does not constitute an offer to sell any securities or the solicitation of an offer to buy any securities.
Key Takeaways for Investment
Revenue Producing: QHSLab’s business model generates recurring revenue for the company itself and its medical practitioner clients. This revenue comes from a large and continuously expanding addressable end market.
Positioned for Growth: We are favorably aligned with industry growth drivers, including the heightened need and acceptance of digital medicine and virtual care, particularly the current population mental health crisis.
Target Customer Base: We have an active pipeline of organic growth opportunities, including expanding product portfolio and distribution channels and significant long-term potential to leverage QHSLab’s cost structure.
Strong Leadership: We are led by a highly energized and experienced management and medical advisory team with a substantial runway of opportunity for shareholders.
Financial Turnaround: Narrowing Net Loss with 51% Revenue Growth and 71% Increase in Gross Profit
Building on a record-breaking year of robust revenue growth and enhanced profitability, QHSLab is primed for exponential expansion. Strategic investment will amplify market penetration, accelerate product innovation, and fuel customer acquisition, positioning the company for transformative impact in healthcare technology and delivering exceptional returns.
Corporate Presentation – April 2025 Information is based on 12 months ending December 31, 2023 and 2024
Path to Profitability
Revenue Growth:
- Revenue jumped 51% year-over-year, reaching $2.1M for 2024.
- This growth reflects the increasing adoption of our solutions and a strong market presence.
Profitability Milestone:
- After years of investment, QHSLab is approaching profitability narrowing the net loss to $259,000, an improvement from $468,000 in 2023.
- Gross profit climbed to $1.4M, with better cost management fueling margins.
Operational Efficiency:
- Operating expenses remain well-managed, with administrative costs declining as we scale.
- Key investments in R&D and marketing support sustainable growth while maintaining financial discipline.
Strengthened Cash Position:
- Cash on hand nearly tripled to $157,000, ensuring liquidity to support operations.
Repayment of loans underscores our focus on reducing debt and financial prudence.
Growth Potential:
- With improving margins, QHSLab is positioned for scalable growth and future development opportunities.
Information is based on 12 months ending December 31, 2024
Highly-Profitable Business Model
Our scalable and straightforward business model enables providers to deliver better care while generating additional revenue. Here’s how our key revenue streams break down:
Allergy Diagnostic Kits:
$100 per test → $12,000 annually per provider
Immunotherapy Treatments:
$500 per patient annually → $10,000 per provider
Digital Health Tools:
$20–$40 per patient → $12,000–$24,000 annually per provider
Clinical Studies:
Revenue opportunities through grants and partnerships, including NSF STTR and Global Health initiatives
Highly-Profitable Business Model
A single provider using our full suite of solutions can generate $30,000–$50,000 annually for QHSLab. In the medium–term scaling this across 250–300 providers translates to $10M+ in annual revenue.
Leveraging Our Strengths & Competitive Advantages
Product Profile:
Exclusive product line featuring FDA-cleared diagnostic equipment, widely accepted by Medicare and private insurance providers.
Advanced Technology Platform:
The QHSLab Expert System efficiently processes large volumes of data with exceptional accuracy and precision. It is highly scalable, supporting unlimited simultaneous user sessions without performance loss.
Compelling Business Model:
Empowers medical practitioners to retain patients within their care by offering services through medical assistants, reducing the need for specialist referrals. This approach generates additional revenue with minimal disruption to existing workflows.
Comprehensive Applications and Industry Expertise:
New product development is guided by a deep understanding of customer needs, ensuring tailored and innovative solutions.
Experienced Leadership and Advisory Team:
A well-rounded team with extensive medical technology and business development expertise offers a synergistic approach to innovation and growth.
Vision and Execution: Transforming Primary Care
Our Dedication:
To revolutionize patient care through well-integrated programs not only sets new industry standards but also positively impacts the overall well-being of patients.
Our Mission:
To improve the quality of life for individuals and populations by utilizing physician-directed digital medicine, point-of-care solutions, and innovative preventive health technologies while enabling our physician clients to improve the health of their practices.
Execution:
- On Target – Scale to 300+ practices, targeting $10M+ annual revenue.
- Secure grant funding (e.g., NSF STTR) to support innovation and research.
- Expand sales efforts and accelerate market adoption.
2025 Milestones:
- Q1: Launch new interactive reimbursable programs and establish partnerships.
- Q2: Roll out behavioral health center(s) via licensing.
- Q3: Expand salesforce in TX, GA, NY.
- Q4: Scale operations and onboard practices.
The Problem: Primary care gaps are failing millions of patients, driving untreated conditions and worsening outcomes.
Doctor Lack Time and Tools:
18 minutes* per patient visit —too short for comprehensive care. 40%** of mental health issues and 50% of allergy symptoms go undiagnosed. (*Source: Annals of Family Medicine (2021, **Source: National Alliance on Mental Illness (NAMI); American College of Allergy, Asthma & Immunology (ACAAI).
Patients Are Underserved:
75% of office visits are tied to stress, allergies, or lifestyle factors, yet these issues are poorly addressed.
Lifestyle Factors:
Approximately 40% of primary care office visits are for chronic illnesses in which psychosocial factors play a significant role in etiology and disease progression.
Reimbursement Challenges:
Reimbursement rates for primary care have dropped 30% in the last decade.
Specialist Shortages:
Fewer than 3,000 allergists in the U.S. can’t meet growing patient demand.
Mental Health Concerns:
Between 2006 and 2018, the number of visits during which primary care physicians managed mental health concerns increased by 50%, from about 11% of visits to about 16%.
The True Cost of Gaps in Primary Care: Too Many Patients, Too Little Time leading to Overwhelmed Providers, Underserved Patients.
Untreated Conditions Escalate:
Millions of undiagnosed and poorly managed conditions lead to preventable complications and chronic illnesses.
Quality of Care Falls Short:
Even when patients receive care, rushed visits and limited insights result in suboptimal outcomes.
Rising Healthcare Costs:
Preventable hospitalizations and advanced treatments drive up patient costs and system costs. Impact on Lives and Practices: Patients suffer, providers burn out, and the system struggles to deliver effective, sustainable care.
With over 100,000 user cases studied, QHSLab, reduces the primary care gap. Moving from reactive to proactive, empowering doctors with the insights they need to deliver exceptional care.
The True Cost of Gaps in Primary Care: Too Many Patients, Too Little Time leading to Overwhelmed Providers, Underserved Patients.
Advanced Patient Engagement:
Interactive digital tools collect meaningful data from patients, uncovering hidden symptoms.
Data-Driven Insights:
Robust back-end organizes patient input into actionable insights for physicians.
Empowering Physicians:
Comprehensive reports reduce guesswork and enable evidence-based care.
Proven Financial Benefit:
Practices gain $10,000+ monthly in new reimbursements using QHSLab.
By engaging patients in a user-friendly, guided process outside the clinic, QHSLab unearths hidden conditions and connects the insights directly to the doctor.
Transforming Patient Data into Clinical Insights and Better Health Outcomes
Untreated Conditions Escalate:
Millions of undiagnosed and poorly managed conditions lead to preventable complications and chronic illnesses.
Quality of Care Falls Short:
Even when patients receive care, rushed visits and limited insights result in suboptimal outcomes.
Rising Healthcare Costs:
Preventable hospitalizations and advanced treatments drive up patient costs and system costs. Impact on Lives and Practices: Patients suffer, providers burn out, and the system struggles to deliver effective, sustainable care.
With over 100,000 user cases studied, QHSLab, reduces the primary care gap. Moving from reactive to proactive, empowering doctors with the insights they need to deliver exceptional care.
